Article
Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer.
Scientific reports - 30 Apr 2014
Yasunaga Masahiro, Matsumura Yasuhiro
Abstract excerpt
The treatment of colorectal cancer (CRC) might be improved by the identification of a signalling pathway that could be targeted with novel therapeutics. The results of this study indicate that the taurine transporter SLC6A6 is highly expressed in CRC cells compared with normal colonocytes. SLC6A6 knockdown (KD) attenuated cell survival and was accompanied by enhanced drug sensitivity to 5-fluorouracil (5-FU),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
